Literature DB >> 31621558

Public Health Interventions for Osteoarthritis - updates on the Osteoarthritis Action Alliance's efforts to address the 2010 OA Public Health Agenda Recommendations.

Leigh F Callahan1, Kirsten R Ambrose2, Allison L Albright2, Mary Altpeter2, Yvonne M Golightly3, Katie F Huffman2, Amanda E Nelson4, Serena E Weisner2.   

Abstract

Osteoarthritis (OA) is a painful joint disease affecting more than 32.5 million adults in the US and over 350 million adults worldwide. The prevalence is expected to rise continually over the next several decades with significant impacts to societal health and economic costs as well as individuals' daily activities and quality of life. In 2008, the Centers for Disease Control and Prevention (CDC) and the Arthritis Foundation (AF) led a collaborative effort to address approaches to reduce the burden of OA via public health interventions, policies (systems and environmental), and communication strategies. This collaboration resulted in the National Public Health Agenda for OA (OA Agenda), which was vetted by more than 75 stakeholder organisations and released in 2010. The OA Agenda listed ten recommendations focused on public health interventions for OA including weight management, physical activity, self-management education, and injury prevention, and policies, systems, communication, research and evaluation. In 2011, the CDC and AF mobilised the OA Action Alliance (OAAA), a national coalition of organisations concerned with mitigating the public health impact of OA, to operationalise the recommendations set forth in the OA Agenda. Since then, the OAAA has grown to include more than 110 organisations that work collectively to increase awareness about the prevention and management of OA, provide educational resources, and expand access to evidence-based programmes for target audiences including individuals with OA, community-based organisations, healthcare systems and providers, and policymakers. This review highlights the OAAA's progress to date in addressing the OA Agenda recommendations; successes and challenges in delivery of effective communication, programmes, and resources; and future implications.

Entities:  

Mesh:

Year:  2019        PMID: 31621558

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  Circular RNA Derived from Vacuolar ATPase Assembly Factor VMA21 Suppresses Lipopolysaccharide-Induced Apoptosis of Chondrocytes in Osteoarthritis (OA) by Decreasing Mature miR-103 Production.

Authors:  Demeng Yang; Xinyuan Hu; Yuan Chen; Changgeng Wang
Journal:  Mol Biotechnol       Date:  2022-02-09       Impact factor: 2.695

2.  Preliminary study on the assessment of early cartilage degeneration by quantitative ultrashort echo time magnetic resonance imaging in vivo.

Authors:  Xiaolian Su; Yixuan Zhang; Qiuming Gao; Zonghui Liang; Lidi Wan; Lin Zhang; Guangyu Tang
Journal:  Quant Imaging Med Surg       Date:  2022-07

3.  Exploring Anatomo-Morphometric Characteristics of Infrapatellar, Suprapatellar Fat Pad, and Knee Ligaments in Osteoarthritis Compared to Post-Traumatic Lesions.

Authors:  Chiara Giulia Fontanella; Elisa Belluzzi; Assunta Pozzuoli; Manuela Scioni; Eleonora Olivotto; Davide Reale; Pietro Ruggieri; Raffaele De Caro; Roberta Ramonda; Emanuele Luigi Carniel; Marta Favero; Veronica Macchi
Journal:  Biomedicines       Date:  2022-06-09

4.  Effect of femoral posterior condyle offset on knee joint function after total knee replacement: a network meta-analysis and a sequential retrospective cohort study.

Authors:  Yimin Zhang; Jun Wang; Miao Zhang; Yun Xu
Journal:  J Orthop Surg Res       Date:  2021-02-10       Impact factor: 2.359

5.  Prediction of knee osteoarthritis progression using radiological descriptors obtained from bone texture analysis and Siamese neural networks: data from OAI and MOST cohorts.

Authors:  Ahmad Almhdie-Imjabbar; Khac-Lan Nguyen; Hechmi Toumi; Rachid Jennane; Eric Lespessailles
Journal:  Arthritis Res Ther       Date:  2022-03-08       Impact factor: 5.156

Review 6.  Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials.

Authors:  Di Zhao; Ling-Feng Zeng; Gui-Hong Liang; Jian-Ke Pan; Ming-Hui Luo; Yan-Hong Han; Jun Liu; Wei-Yi Yang
Journal:  EFORT Open Rev       Date:  2022-07-05

Review 7.  Outcomes of High Tibial Osteotomy With Versus Without Mesenchymal Stem Cell Augmentation: A Systematic Review and Meta-analysis.

Authors:  Si Heng Sharon Tan; Yiu Tsun Kwan; Wei Jian Neo; Jia Yan Chong; Tze Yin Joshua Kuek; Jun Ze Fabian See; James Hoipo Hui
Journal:  Orthop J Sports Med       Date:  2021-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.